Hemant Surgical Industries, 543916, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

402.69
50.08
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

396.27
N/A
N/A

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 24 Mar 23 Mar 22 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales - 105.61 109.15 103.57 39.62 31.78 31.29 28.37 24.40 23.50 19.75 Net Sales Growth - -3.24% 5.39% 161.41% 24.67% 1.57% 10.29% 16.27% 3.83% 18.99% Cost Of Goods Sold - 77.51 80.46 81.69 33.22 27.63 26.27 23.29 18.22 19.31 16.52 Gross Profit - 28.10 28.68 21.87 6.40 4.15 5.02 5.08 6.18 4.19 3.23 GP Margin - 26.61% 26.28% 21.12% 16.15% 13.06% 16.04% 17.91% 25.33% 17.83% 16.35% Total Expenditure - 95.14 98.60 97.27 37.30 30.37 29.46 26.18 21.84 21.63 18.43 Power & Fuel Cost - 0.75 0.69 0.55 0.18 0.15 0.17 0.19 0.22 0.11 0.03 % Of Sales - 0.71% 0.63% 0.53% 0.45% 0.47% 0.54% 0.67% 0.90% 0.47% 0.15% Employee Cost - 5.73 5.51 4.62 0.79 0.56 0.53 0.73 0.72 0.50 0.35 % Of Sales - 5.43% 5.05% 4.46% 1.99% 1.76% 1.69% 2.57% 2.95% 2.13% 1.77% Manufacturing Exp. - 0.82 1.21 0.85 1.01 0.30 0.91 0.61 1.02 0.41 0.68 % Of Sales - 0.78% 1.11% 0.82% 2.55% 0.94% 2.91% 2.15% 4.18% 1.74% 3.44% General & Admin Exp. - 5.89 5.59 3.74 1.70 1.42 1.34 1.03 1.23 0.99 0.50 % Of Sales - 5.58% 5.12% 3.61% 4.29% 4.47% 4.28% 3.63% 5.04% 4.21% 2.53% Selling & Distn. Exp. - 4.18 5.00 4.82 0.28 0.23 0.20 0.30 0.41 0.29 0.33 % Of Sales - 3.96% 4.58% 4.65% 0.71% 0.72% 0.64% 1.06% 1.68% 1.23% 1.67% Miscellaneous Exp. - 0.26 0.14 1.00 0.11 0.07 0.02 0.02 0.01 0.01 0.33 % Of Sales - 0.25% 0.13% 0.97% 0.28% 0.22% 0.06% 0.07% 0.04% 0.04% 0.05% EBITDA - 10.47 10.55 6.30 2.32 1.41 1.83 2.19 2.56 1.87 1.32 EBITDA Margin - 9.91% 9.67% 6.08% 5.86% 4.44% 5.85% 7.72% 10.49% 7.96% 6.68% Other Income - 4.31 2.35 2.20 0.23 0.62 0.18 0.21 0.18 0.21 0.17 Interest - 0.97 1.99 1.64 1.72 1.35 1.49 1.84 1.89 1.30 0.79 Depreciation - 1.03 0.85 0.75 0.18 0.15 0.17 0.20 0.24 0.21 0.14 PBT - 12.78 10.06 6.11 0.66 0.54 0.36 0.36 0.61 0.56 0.56 Tax - 2.98 2.42 1.50 0.03 0.00 0.00 0.00 0.10 0.10 0.09 Tax Rate - 23.32% 24.06% 24.55% 4.55% 0.00% 0.00% 0.00% 16.39% 17.86% 16.07% PAT - 9.80 7.64 4.61 0.63 0.54 0.36 0.36 0.51 0.47 0.47 PAT before Minority Interest - 9.80 7.64 4.61 0.63 0.54 0.36 0.36 0.51 0.47 0.47 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 9.28% 7.00% 4.45% 1.59% 1.70% 1.15% 1.27% 2.09% 2.00% 2.38% PAT Growth - 28.27% 65.73% 631.75% 16.67% 50.00% 0.00% -29.41% 8.51% 0.00% EPS - 7.54 5.88 3.55 0.48 0.42 0.28 0.28 0.39 0.36 0.36

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 54.86 23.36 13.15 4.09 3.84 3.54 3.15 2.83 1.95 Share Capital 10.44 7.68 2.00 1.50 1.50 1.50 1.50 1.50 1.00 Total Reserves 44.42 15.68 11.15 2.59 2.34 2.04 1.65 1.33 0.95 Non-Current Liabilities 3.99 3.67 4.26 0.80 0.87 3.04 3.61 4.54 3.68 Secured Loans 3.54 3.06 4.08 0.74 0.59 2.52 3.24 4.52 1.91 Unsecured Loans 0.00 0.00 0.00 0.06 0.28 0.52 0.37 0.03 1.76 Long Term Provisions 0.38 0.32 0.28 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 37.79 37.66 36.97 21.50 17.06 14.62 10.09 4.61 6.62 Trade Payables 24.61 24.19 20.69 11.57 6.53 4.22 6.08 4.05 5.57 Other Current Liabilities 8.13 7.80 9.04 0.55 0.53 0.59 0.03 0.36 0.87 Short Term Borrowings 2.15 2.42 4.43 9.31 9.71 9.59 3.80 0.00 0.00 Short Term Provisions 2.91 3.25 2.80 0.07 0.29 0.21 0.18 0.21 0.18 Total Liabilities 96.64 64.69 54.38 26.39 21.77 21.20 16.85 11.98 12.25 Net Block 17.66 13.15 11.57 1.41 1.57 1.75 1.15 0.79 0.70 Gross Block 24.03 18.66 16.31 1.57 1.77 1.99 3.35 2.78 2.55 Accumulated Depreciation 6.37 5.51 4.74 0.17 0.20 0.24 2.20 1.99 1.85 Non Current Assets 27.34 17.98 16.75 4.32 3.01 4.37 3.02 0.79 0.70 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 4.93 0.36 0.82 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 4.75 4.47 4.36 2.91 1.43 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 2.63 1.87 0.00 0.00 Current Assets 69.30 46.71 37.62 22.07 18.77 16.82 13.82 11.19 11.54 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 21.05 14.81 12.84 15.39 14.35 11.77 7.19 4.04 3.56 Sundry Debtors 21.74 17.20 15.66 5.57 3.86 3.53 3.81 3.95 4.24 Cash & Bank 13.17 8.46 5.83 0.94 0.48 0.46 1.73 2.08 2.03 Other Current Assets 13.34 0.00 0.00 0.00 0.08 1.06 1.09 1.11 1.71 Short Term Loans & Adv. 13.10 6.25 3.30 0.18 0.08 1.06 1.09 1.11 1.71 Net Current Assets 31.50 9.05 0.66 0.57 1.70 2.20 3.73 6.57 4.92 Total Assets 96.64 64.69 54.37 26.39 21.78 21.19 16.84 11.98 12.25

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 14
Cash From Operating Activity -7.56 6.30 12.06 0.00 PBT 12.78 10.06 6.11 0.00 Adjustment 0.84 3.76 2.26 0.00 Changes in Working Capital -17.96 -4.98 4.04 0.00 Cash after chg. in Working capital -4.34 8.83 12.41 0.00 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -3.22 -2.53 -0.35 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -8.97 -2.97 -0.05 0.00 Net Fixed Assets -5.37 -2.35 -14.74 Net Investments -4.57 0.46 -0.82 Others 0.97 -1.08 15.51 Cash from Financing Activity 21.24 -0.70 -7.70 0.00 Net Cash Inflow / Outflow 4.71 2.63 4.31 0.00 Opening Cash & Equivalents 8.46 5.83 1.52 0.00 Closing Cash & Equivalent 13.17 8.46 5.83 0.00

Financial Ratios

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 52.55 30.41 41.09 272.47 255.98 235.47 209.51 188.29 194.41 ROA 12.15% 12.83% 9.49% 1.51% 1.67% 2.70% 3.25% 3.86% 2.85% ROE 25.06% 41.84% 42.56% 9.16% 9.72% 15.37% 15.72% 19.60% 17.93% ROCE 29.87% 45.15% 32.89% 12.92% 14.41% 18.77% 20.78% 20.71% 20.49% Fixed Asset Turnover 4.95 6.24 6.43 18.72 15.10 9.14 7.66 7.41 7.29 Receivable days 67.28 54.93 35.11 55.00 47.56 54.92 60.31 75.72 83.23 Inventory Days 61.96 46.23 48.77 173.40 167.98 141.77 87.20 70.26 69.95 Payable days 114.88 101.79 74.60 112.57 68.14 74.76 77.12 93.63 108.80 Cash Conversion Cycle 14.36 -0.63 9.29 115.82 147.40 121.93 70.39 52.35 44.38 Total Debt/Equity 0.12 0.30 0.74 2.47 2.76 3.58 2.36 1.61 1.89 Interest Cover 14.15 6.06 4.73 1.24 1.19 1.32 1.43 1.71 1.57

Top Investors:

singularity large value fund i

wealthwave capital fund

singularity equity fund i

singularity large value fund iii

pm investment

harsha venkatesh

Annual Reports:

News Update:

Hemant surgical Industries secures purchase order worth Rs 82.89 crore
12th Sep 2025, 10:50 AM

The order is for supply of Ultraportable Handheld portable X-ray Machines along with its other utilities
Read More

Hemant Surgical Industries Ltd.

Medical Equipment/Supplies/Accessories

BSE: 543916 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Hemant Surgical Industries Ltd.

Medical Equipment/Supplies/Accessories

BSE: 543916 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: